Abeona Therapeutics (ABEO) Inventory (2011 - 2026)

Abeona Therapeutics (ABEO) recorded quarterly Inventory of $6.1 million in Q1 2026, up 10.21% quarter-over-quarter from $5.5 million in Q4 2025.

Abeona Therapeutics (ABEO) Inventory (2011 - 2026) Analysis & Trends

Abeona Therapeutics' Inventory history runs 5 years deep, the most recent figure standing at $6.1 million for Q1 2026.

In Q1 2026, Inventory changed N/A year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at $6.1 million (changed N/A YoY), while the FY2025 annual figure was $5.5 million, changed N/A from the prior year.
Inventory was $6.1 million for Q1 2026 at Abeona Therapeutics, up from $5.5 million in the prior quarter.
In the past five years, Inventory ranged from a high of $6.1 million in Q1 2026 to a low of $2.7 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Alterity Therapeutics	723,416.35 Bn	723,416.32 Bn	-	-
2	Belite Bio	57,340.00 Bn	57,340.00 Bn	-	-
3	Quantum Biopharma	19,125.08 Bn	19,125.08 Bn	-	-
4	Legend Biotech	3,262.00 Bn	3,261.71 Bn	242.10 Mn	32.00 Mn
5	Akari Therapeutics	1,789.67 Bn	1,789.67 Bn	-	-
6	Evaxion A	1,480.39 Bn	1,480.37 Bn	-	-
7	Psyence Biomedical	241.78 Bn	241.78 Bn	-	-
8	Vertex Pharmaceuticals	113.54 Bn	106.29 Bn	2.59 Bn	1.77 Bn
9	Abivax	94.26 Bn	94.26 Bn	-	-
10	Abeona Therapeutics	309.15 Mn	140.88 Mn	6.02 Mn	6.05 Mn

Download Data